Li, X., Cui, L., Chen, W., Fang, Y., Shen, G., Li, Z., . . . Wu, L. (2021). QiangGuYin Modulates the OPG/RANKL/RANK Pathway by Increasing Secretin Levels during Treatment of Primary Type I Osteoporosis. Hindawi Limited.
Cita Chicago Style (17a ed.)Li, Xuefei, Longkang Cui, Wenhua Chen, Yuan Fang, Gaobo Shen, Zhen Li, Bingbing Zhang, y Lianguo Wu. QiangGuYin Modulates the OPG/RANKL/RANK Pathway by Increasing Secretin Levels During Treatment of Primary Type I Osteoporosis. Hindawi Limited, 2021.
Cita MLA (8a ed.)Li, Xuefei, et al. QiangGuYin Modulates the OPG/RANKL/RANK Pathway by Increasing Secretin Levels During Treatment of Primary Type I Osteoporosis. Hindawi Limited, 2021.
Precaución: Estas citas no son 100% exactas.